SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-23-006728
Filing Date
2023-08-02
Accepted
2023-08-02 17:06:16
Documents
2
Period of Report
2023-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1748
2 POWER OF ATTORNEY poa_dananberg.htm EX-24.1 7364
  Complete submission text file 0001567619-23-006728.txt   10472
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Dananberg Jamie (Reporting) CIK: 0001734424 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39402 | Film No.: 231136819